OPK

1.50

0.66% -0.01

Dopo l'orario di chiusura: 1.49 -0.01 -0.67%

Opko Health Inc (OPK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché OPK Giù? Forum Previsione

Precedente Chiudi:

$1.51

Aprire:

$1.49

Volume 24 ore:

2.71M

Relative Volume:

0.77

Capitalizzazione di mercato:

$1.12B

Reddito:

$581.12M

Utile/perdita netta:

$-212.92M

Rapporto P/E:

-5.4785

EPS:

-0.2738

Flusso di cassa netto:

$-174.22M

1 W Prestazione:

+2.74%

1M Prestazione:

+20.97%

6M Prestazione:

+25.00%

1 anno Prestazione:

+5.63%

Intervallo 1D:

$1.49

$1.53

Intervallo di 1 settimana:

$1.455

$1.53

Portata 52W:

$0.9769

$1.73

Opko Health Inc Stock (OPK) Company Profile

Nome

Opko Health Inc

Settore

Healthcare (1082)

Industria

Diagnostics & Research (50)

Telefono

305-575-4181

Indirizzo

4400 BISCAYNE BLVD., MIAMI, FL

Dipendente

2,275

Cinguettio

Prossima data di guadagno

2026-07-27

Ultimi documenti SEC

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, NTRA, A, IQV

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OPK Opko Health Inc	1.50	1.09B	581.12M	-212.92M	-174.22M	-0.2738
TMO Thermo Fisher Scientific Inc	630.70	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	215.68	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	338.70	46.82B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	157.69	44.14B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	262.38	42.15B	16.63B	1.39B	2.12B	8.0674

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-20	Iniziato	JP Morgan	Neutral
2025-10-31	Downgrade	Jefferies	Buy → Hold
2025-04-25	Iniziato	JP Morgan	Neutral
2023-06-29	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-12-15	Iniziato	H.C. Wainwright	Buy
2022-01-24	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-06-21	Iniziato	Ladenburg Thalmann	Buy
2019-11-25	Iniziato	Piper Jaffray	Overweight
2018-03-02	Downgrade	JP Morgan	Neutral → Underweight
2017-09-14	Downgrade	JP Morgan	Overweight → Neutral
2016-06-21	Reiterato	Standpoint Research	Buy
2016-06-03	Iniziato	Standpoint Research	Buy
2016-03-31	Reiterato	Barrington Research	Outperform
2015-10-16	Iniziato	JP Morgan	Overweight
2015-09-11	Downgrade	Jefferies	Buy → Hold
2015-03-03	Downgrade	Oppenheimer	Outperform → Perform
2014-05-12	Reiterato	Oppenheimer	Outperform
2014-03-14	Iniziato	Oppenheimer	Outperform
2013-11-13	Reiterato	Ladenburg Thalmann	Buy
2013-05-30	Reiterato	Ladenburg Thalmann	Buy
2012-10-22	Iniziato	Barrington Research	Outperform
2011-12-01	Reiterato	Ladenburg Thalmann	Buy
2011-07-14	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Opko Health Inc Borsa (OPK) Ultime notizie

Aug 20, 2026

COCP: 5 Million Private Placement with OPKO Health - Smartkarma

Aug 20, 2026

Aug 19, 2026

Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Zacks Investment Research

Aug 19, 2026

OPK Raises $125 Million Against Royalties: What Investors Should Know - Yahoo Finance

Aug 19, 2026

OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? - TradingView

Aug 19, 2026

Zacks Research Has Positive View of OPKO Health Q3 Earnings - MarketBeat

Aug 19, 2026

Aug 18, 2026

OPKO (OPK) Latest Results Brief: EPS Prints Above Forecast in the Latest Reading; Shares After the Report: The Market Reaction Is MutedTrough Earnings Signal - Vinanet

Aug 18, 2026

OPKO Health Secures $125 Million Financing Against Mazdutide Royalties - Yahoo Finance

Aug 18, 2026

Should OPKO Health’s Royalty-Backed US$125 Million Financing Shift Matter to OPKO Health (OPK) Investors? - Sahm

Aug 18, 2026

Aug 16, 2026

OPKO Health (OPK) Retreats to $1.38 as Support at $1.31 Comes into FocusMomentum Surge Alerts - vinanet.vn

Aug 16, 2026

Aug 15, 2026

OPKO Health (OPK) Raises $125 Million, Is The Upside Already Priced In? - Sahm

Aug 15, 2026

Aug 14, 2026

OPKO Health Raises $125 Million in Senior Secured Debt Financing - Minichart

Aug 14, 2026

OPKO Health (OPK) Slips to $1.38, Pressing Key Support at $1.31ATR Trailing Stop - Vinanet

Aug 14, 2026

OPKO Health Raises $125M Through Senior Secured Notes Backed by Mazdutide Royalties - Kalkine Media

Aug 14, 2026

OPKO Health Raises $125 Million in Additional Royalty-Backed Notes Under Amended HCR Agreement - TradingView

Aug 14, 2026

OPKO Health (NASDAQ:OPK) Trading Down 5.4%Here's What Happened - MarketBeat

Aug 14, 2026

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Aug 14, 2026

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - OPKO Health, Inc.

Aug 14, 2026

Aug 13, 2026

OPKO Health, Inc. Expands Strategic Relationship with Healthcare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - marketscreener.com

Aug 13, 2026

OPKO Health secures $125m financing backed by mazdutide royalties - Investing.com Nigeria

Aug 13, 2026

OPKO Health Issues Additional $125 Million in Senior Notes Secured by Mazdutide Royalties - marketscreener.com

Aug 13, 2026

OPKO Health raises $125M in notes backed by mazdutide royalties - StreetInsider

Aug 13, 2026

OPKO Issues $125M Notes While Keeping Future Mazdutide Royalties - Stock Titan

Aug 13, 2026

Aug 12, 2026

OPKO Health, Inc. announced that it has received $375 million in funding from Healthcare Royalty Management, LLC - marketscreener.com

Aug 12, 2026

Aug 11, 2026